The Drugs Controller General of India(DCGI) on Tuesday has given emergency use authorization (EUA) to Bharat Biotech for the intranasal vaccine.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/SCTkZdu
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Bharat Biotech applies for market authorisation from DCGI for five arms intranasal heterologous booster
https://ift.tt/vJWndzw
No comments:
Post a Comment